Ignite Creation Date:
2024-05-06 @ 1:19 AM
Last Modification Date:
2024-10-26 @ 11:02 AM
Study NCT ID:
NCT01775462
Status:
COMPLETED
Last Update Posted:
2016-01-20
First Post:
2013-01-17
Brief Title:
Phase 2 Study to Evaluate Safety Pharmacokinetics Immunogenicity and PharmacodynamicsEfficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia XLHED
Sponsor:
Organization:
Edimer Pharmaceuticals
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
6
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: